The 5 most interesting analyst questions from Covista’s Q3 earnings call
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- CVSA Covista-3.5% 5d
Named in this report.
Indirectly affected
- XLY Consumer Discretionary Select Sector SPDR+5.7% 30d
Consumer Discretionary Select Sector SPDR holds the consumer sector that CVS Health belongs to, so it often moves with news about it.
- CVS CVS Health-10.0% 30d
CVS Health is a peer of CVS Health in drug stores and proprietary stores; rivals often move on the same news.
- AMZN Amazon.com+6.7% 30d
Amazon.com is a large consumer company like CVS Health; big names in a sector often move together.
- ULTA Ulta Beauty+16.7% 30d
Ulta Beauty is a large consumer company like CVS Health; big names in a sector often move together.
- CPNG Coupang+22.8% 30d
Coupang is a large consumer company like CVS Health; big names in a sector often move together.
- CDW Cdw+15.4% 30d
Cdw is a large consumer company like CVS Health; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CVSA | +5.78% | +1.59% | base | -0.37% | -1.22% | -0.19% | -9.25% |
| XLY | -0.96% | -0.06% | base | +2.40% | +1.70% | +6.04% | +1.71% |
| CVS | +2.55% | -0.35% | base | -1.89% | +1.35% | -11.38% | -9.86% |
| AMZN | +3.66% | +5.97% | base | +2.24% | +4.32% | +10.73% | +7.98% |
| ULTA | -2.36% | -3.31% | base | -0.44% | -0.83% | +3.17% | +1.03% |
| CPNG | -4.31% | -1.67% | base | +2.30% | +6.12% | +18.65% | +14.44% |
| CDW | +6.14% | +5.80% | base | -2.09% | -2.82% | +9.82% | +2.86% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
The 5 most interesting analyst questions from Covista’s Q3 earnings call Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMZN | that day | +2.24% | final price |
| AMZN | the next day | +4.32% | final price |
| AMZN | two days later | +10.73% | final price |
| AMZN | three days later | +7.98% | final price |
| AMZN | three days earlier | +5.97% | final price |
| AMZN | five days earlier | +3.66% | final price |
| CDW | that day | -2.09% | final price |
| CDW | the next day | -2.82% | final price |
| CDW | two days later | +9.82% | final price |
| CDW | three days later | +2.86% | final price |
| CDW | three days earlier | +5.80% | final price |
| CDW | five days earlier | +6.14% | final price |
| CPNG | that day | +2.30% | final price |
| CPNG | the next day | +6.12% | final price |
| CPNG | two days later | +18.65% | final price |
| CPNG | three days later | +14.44% | final price |
| CPNG | three days earlier | -1.67% | final price |
| CPNG | five days earlier | -4.31% | final price |
| CVS | that day | -1.89% | final price |
| CVS | the next day | +1.35% | final price |
| CVS | two days later | -11.38% | final price |
| CVS | three days later | -9.86% | final price |
| CVS | three days earlier | -0.35% | final price |
| CVS | five days earlier | +2.55% | final price |
| CVSA | that day | -0.37% | final price |
| CVSA | the next day | -1.22% | final price |
| CVSA | two days later | -0.19% | final price |
| CVSA | three days later | -9.25% | final price |
| CVSA | three days earlier | +1.59% | final price |
| CVSA | five days earlier | +5.78% | final price |
| ULTA | that day | -0.44% | final price |
| ULTA | the next day | -0.83% | final price |
| ULTA | two days later | +3.17% | final price |
| ULTA | three days later | +1.03% | final price |
| ULTA | three days earlier | -3.31% | final price |
| ULTA | five days earlier | -2.36% | final price |
| XLY | that day | +2.40% | final price |
| XLY | the next day | +1.70% | final price |
| XLY | two days later | +6.04% | final price |
| XLY | three days later | +1.71% | final price |
| XLY | three days earlier | -0.06% | final price |
| XLY | five days earlier | -0.96% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna sold Cvs Health (CVS) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Cvs Health (CVS) (held by a spouse), worth $1,001 - $15,000 on 24 Aug 2026. That is 70 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Pete Sessions sold Amazon Com (AMZN), worth $15,001 - $50,000 on 27 Oct 2026. That is 6 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Pete Sessions sold Amazon Com (AMZN) (held by a spouse), worth $100,001 - $250,000 on 2 Oct 2026. That is 31 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Michael T. McCaul sold Amazon Com (AMZN) (held by a spouse), worth $1,001 - $15,000 on 28 Aug 2026. That is 66 days before publication. Filed 14 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Coupang (CPNG), worth $15,001 - $50,000 on 28 Aug 2026. That is 66 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Coupang (CPNG), worth $1,001 - $15,000 on 10 Aug 2026. That is 84 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold CDW, worth $500,001 - $1,000,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought CDW, worth $1,001 - $15,000 on 19 Aug 2026. That is 75 days before publication. Filed 10 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“The 5 most interesting analyst questions from Covista’s Q3 earnings call” scores 12 out of 100. The score uses 1 sources.